10x Genomics to Report Third Quarter Financial Results on November 10, 2020
October 13 2020 - 4:15PM
10x Genomics (Nasdaq: TXG) today announced it will report financial
results for the third quarter 2020 after market close on Tuesday,
November 10, 2020. The company’s management will webcast a
corresponding conference call beginning at 2:00 p.m. Pacific Time /
5:00 p.m. Eastern Time to discuss its results, business
developments and outlook.
Live audio of the webcast will be available on the
“Investors” section of the company website at: www.10xgenomics.com.
The webcast will be archived and available for replay for at least
45 days after the event.
About 10x Genomics10x Genomics
is a life science technology company building products to
interrogate, understand and master biology to advance human health.
The company’s integrated solutions include instruments, consumables
and software for analyzing biological systems at a resolution and
scale that matches the complexity of biology. 10x Genomics products
have been adopted by researchers around the world including 97 of
the top 100 global research institutions and 19 of the top 20
global pharmaceutical companies, and have been cited in over 1,750
research papers on discoveries ranging from oncology to immunology
and neuroscience. The company’s patent portfolio comprises more
than 825 issued patents and patent applications.
Disclosure Information10x Genomics
uses filings with the Securities and Exchange Commission, its
website (www.10xgenomics.com), press releases, public conference
calls, public webcasts and its social media accounts as means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD.
ContactsMedia:media@10xgenomics.comInvestors:investors@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Apr 2023 to Apr 2024